Russian Pharmaceutical Industry Leader

R&D cooperation

Scientific development сontests

The Pharmasintez company receives assistance with financial grants from Research and Development National Organisations. This includes the participation in the Pharma-2020 program on the FTP "Research and development in the priority directions of development of a scientific and technological complex in Russia for 2014-2020".

The research teams supported by Pharmasyntez also participate in receiving grants by the Russian scientific fund (RSF).

JSC Pharmasyntez is one of the main industrial partners of the Ministry of Education and Science of the Russian Federation.

Co-operation

We are open for cooperation with international partners. Our priority is the new original medicines production at our production sites in Russia.

We strive for compliance with the strictest quality standards and we use the latest technologies to make this possible. Scientific research is conducted according to requirements of ICH9 and the following leading regulatory standards: The US Food and Drug Administration (USFDA), The European Medicines Agency (EMA), Ministry of Health of the Russian Federation, Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor).

Turning to the scientific teams, we want to note that your participation in the projects will help to successfully implement the plans and will allow promising developments to reach the consumer. We sincerely hope that the joint efforts of scientists, as well as the experience and the desire of our company to bring to the patients the best medicines, allows us to implement projects for the creation of new medicines.

Cooperation with research teams
We are proud to cooperate with the leading universities in Russia:
  • Lomonosov Moscow State University
  • Irkutsk State Academy of Medicine
  • Novosibirsk Tuberculosis Research Institute
  • Irkutsk Scientific Center of Surgery and Traumatology
  • Angarsk State Technical University
  • Saint Petersburg Research Institute for Phthisiopulmonology
  • Ural Research Institute for Phthisiopulmonology
  • A.E. Favorsky Irkutsk Institute of Chemistry
  • Siberian Institute of Plant Physiology and Biochemistry
  • Central Research Institute of Tuberculosis
  • G.A. Krestov Institute of Solution Chemistry
We highly appreciate our foreign partners
  • Apotex, Canada
  • ARCHIVEL FARMA, Spain
  • Biocon Limited, India
  • Charles River Laboratories, Germany
  • Dong-A Pharmaceutical Co., Ltd. Seoul, S.Korea
  • Laila Pharmaceuticals, India
  • Lupin Limited, India
  • MSN Pharmachem Pvt. Ltd., India
  • Oasmia Pharmaceutical AB, Sweden
  • Reliance Life Sciences Pvt. Ltd, India
  • SUN Group (EURASIA) Limited, India
  • Supratek Pharma Inc, India
  • Toxikon Europe NV, Belgium
Contacts
Chief R&D Officer
Mikhail Shurygin
Postal Address
Russia, 664040, Irkutsk, p.o. box 17
The address for courier deliveries
Russia, 664040, Irkutsk, Rosa Luxemburg St., 184/1
Communication form
Name*
E-mail*
Subject*
Message*
Captcha*
* — Required fields